HER2 Expression: Beyond the Binary

In this clip, Dr. Bardia details how trastuzumab deruxtecan (T-DXd) functions across the spectrum of HER2 expression, including low and ultra-low categories, demonstrating clinical benefits even where traditional diagnostics show minimal expression.

Topics Covered:
• T-DXd efficacy across HER2 spectrum
• Definitions of HER2-low and ultra-low
• Practical implications for clinical practice